VITA, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 15.933
EU - Europa 5.847
AS - Asia 2.943
Continente sconosciuto - Info sul continente non disponibili 35
OC - Oceania 31
SA - Sud America 19
AF - Africa 8
Totale 24.816
Nazione #
US - Stati Uniti d'America 15.887
CN - Cina 2.134
UA - Ucraina 1.976
IT - Italia 1.344
DE - Germania 685
HK - Hong Kong 571
IE - Irlanda 379
GB - Regno Unito 365
FI - Finlandia 361
PL - Polonia 311
FR - Francia 168
IN - India 115
SE - Svezia 105
BE - Belgio 49
CA - Canada 43
AU - Australia 30
TR - Turchia 30
EU - Europa 29
VN - Vietnam 23
IR - Iran 22
NL - Olanda 16
RU - Federazione Russa 15
AT - Austria 11
CH - Svizzera 10
ES - Italia 9
SG - Singapore 9
HU - Ungheria 8
BR - Brasile 7
GR - Grecia 7
JP - Giappone 6
RO - Romania 6
A1 - Anonimo 5
PE - Perù 5
PH - Filippine 5
SA - Arabia Saudita 5
MU - Mauritius 4
AE - Emirati Arabi Uniti 3
AR - Argentina 3
BD - Bangladesh 3
BG - Bulgaria 3
CI - Costa d'Avorio 3
ID - Indonesia 3
PT - Portogallo 3
SI - Slovenia 3
AM - Armenia 2
CZ - Repubblica Ceca 2
EE - Estonia 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
MX - Messico 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
CL - Cile 1
CO - Colombia 1
EC - Ecuador 1
FK - Isole Falkland (Malvinas) 1
HR - Croazia 1
IM - Isola di Man 1
IS - Islanda 1
JO - Giordania 1
KE - Kenya 1
KR - Corea 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MS - Montserrat 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 24.816
Città #
Fairfield 2.179
Woodbridge 1.782
Jacksonville 1.536
Houston 1.299
Chandler 1.119
Ashburn 1.109
Cambridge 856
Seattle 838
Ann Arbor 807
Wilmington 781
Princeton 720
Hong Kong 564
Nanjing 507
New York 406
Dublin 375
Warsaw 311
Brescia 309
Beijing 250
Helsinki 224
Nanchang 182
Des Moines 159
Dearborn 154
Changsha 144
Milan 136
Shenyang 133
Hebei 124
Lancaster 122
Jinan 121
Tianjin 118
San Diego 106
Jiaxing 80
Hangzhou 60
Rome 55
Zhengzhou 53
Kunming 50
London 50
Shanghai 50
San Mateo 49
Washington 41
Brussels 37
Ningbo 33
Norwalk 33
Toronto 32
Lanzhou 31
Augusta 30
Haikou 30
Orange 30
San Francisco 30
Guangzhou 29
Leawood 28
Boardman 26
Taizhou 26
Verona 24
Dong Ket 22
Kocaeli 21
Monmouth Junction 18
Taiyuan 18
Fuzhou 16
Redwood City 16
Ardabil 15
Lappeenranta 15
Changchun 14
Los Angeles 14
Bologna 13
Coventry 11
Gent 11
Kilburn 11
Palermo 11
Melbourne 10
Mumbai 10
Hounslow 9
Mantova 9
Cagliari 8
Canberra 8
Cologno Monzese 8
Prescot 8
Sydney 8
Turin 8
Frankfurt am Main 7
Manchester 7
Poncarale 7
Bolzano 6
Hefei 6
Moscow 6
Naples 6
New Bedfont 6
Nuremberg 6
Pavia 6
Reggio Calabria 6
Reggio Nell'emilia 6
Rozzano 6
Sesto San Giovanni 6
Acton 5
Athens 5
Bitonto 5
Castellanza 5
Castiglione delle Stiviere 5
Corteno Golgi 5
Falkenstein 5
Florence 5
Totale 18.817
Nome #
Cognitive Remediation Therapy (CRT): presupposti e descrizione. 441
Exome sequencing in schizophrenic patients with high levels of homozygosity identifies novel and extremely rare mutations in the GABA/glutamatergic pathways 254
Il training cognitivo nei pazienti affetti da schizofrenia 175
Predictors of cognitive improvement and normalization under cognitive remediation in patients with schizophrenia. 171
The Effect of Antipsychotic Treatment on Cortical Gray Matter Changes in Schizophrenia: Does the Class Matter? A Meta-analysis and Meta-regression of Longitudinal Magnetic Resonance Imaging Studies 163
The impairment of GABAergic pathway as one of the driver forces in the etiopathogenesis of schizophrenia: evidence from functional studies and gene-set enrichment analyses 163
Cognitive remediation in schizophrenia: current status and future perspectives. 153
Italian Study on Depressive Disorders (STudio Italiano MAlattia Depressiva, or STIMA-D): a nationwide snapshot of the status of treatment for major depression. 153
Correlates of autistic traits among patients with borderline personality disorder 151
Interview-based assessment of cognition in schizophrenia: applicability of the Schizophrenia Cognition Rating Scale (SCoRS) in different phases of illness and settings of care. 144
Combined measure of smooth pursuit eye movements and ventricle-brain ratio in schizophrenic disorders. 141
Psychiatric hospitalization rates in italy before and during covid-19: Did they change? an analysis of register data 137
Does cognitive remediation modify the use of psychiatric services and the patterns of care of patients with schizophrenia? 136
The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia 135
Autism spectrum disorder and schizophrenia: Do they overlap? 132
Looking through autistic features in schizophrenia using the PANSS Autism Severity Score (PAUSS) 131
A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder. 128
Effectiveness of different modalities of cognitive remediation on symptomatological, neuropsychological, and functional outcome domains in schizophrenia: A prospective study in a real-world setting 128
Factors Associated With Response and Resistance to Cognitive Remediation in Schizophrenia: A Critical Review 127
Categorical and dimensional approaches to negative symptoms of schizophrenia: focus on long-term stability and functional outcome. 125
Adult Autism Subthreshold Spectrum (AdAS Spectrum): Validation of a questionnaire investigating subthreshold autism spectrum 125
Effects of cognitive remediation therapy on neurocognition and negative symptoms in schizophrenia: an Italian naturalistic study 124
Psychomotor agitation in subjects hospitalized for an acute exacerbation of Schizophrenia 123
Psychopathologic, neuropsychological and functional outcome measures during cognitive rehabilitation in schizophrenia: A prospective controlled study in a real-world setting. 122
Adult ADHD: Prevalence and Clinical Correlates in a Sample of Italian Psychiatric Outpatients 122
Hyperprolactinemia in antipsychotic-naive patients with first-episode psychosis. 121
Autistic traits in a sample of adult patients with schizophrenia: prevalence and correlates 121
Factors Associated With Brain Heterogeneity in Schizophrenia 121
The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis 119
Cognitive remediation in schizophrenia. 118
A novel homozygous mutation in GAD1 gene described in a schizophrenic patient impairs activity and dimerization of GAD67 enzyme 118
X-linked mental retardation with Marfanoid habitus. First report of four italian patients. 117
Adherence to antipsychotics in schizophrenia. 113
Factors affecting antipsychotic drug discontinuation in the treatment of schizophrenia: Evidence from a naturalistic, retrospective, 18-month follow-up study. 112
A linkage study of schizophrenia to markers within Xp11 near the MAOB gene. 112
Tools for measuring clinical effectiveness. 111
Cognitive remediation in the early course of schizophrenia: a critical review. 111
A roadmap to disentangle the molecular etiology of schizophrenia 110
Virological and immunological study of schizophrenic patients in relation to CT scan abnormality. 110
Age of onset in familial schizophrenia. 109
The relationships of personal resources with symptom severity and psychosocial functioning in persons with schizophrenia: results from the Italian Network for Research on Psychoses study 109
HLA-DR antigens in schizophrenia. 108
Season of birth and cerebral ventricular enlargement in schizophrenia 108
At-risk gambling in patients with severe mental illness. Prevalence and associated features. 107
Attitudes of Italian Psychiatrists Toward the Evaluation of Physical Comorbidities and Sexual Dysfunction in Patients With Schizophrenia. Implications for Clinical Practice 107
Brain morphology in schizophrenic disorder: prevalence and correlates of diffuse (cortical and subcortical) brain atrophy. 106
Brain structural abnormalities at the onset of schizophrenia and bipolar disorder: a meta-analysis of controlled magnetic resonance imaging studies 106
Non pharmacological strategies to enhance adherence and continuity of care in schizophrenia. 106
Alpha reactivity in schizophrenia and in schizophrenic spectrum disorders: demographic, clinical and hemispheric assessment. 105
Time course of cerebral ventricular enlargement in schizophrenia supports the hypothesis of its neurodevelopmental nature. 105
Effectiveness of Cognitive Remediation in Early Versus Chronic Schizophrenia: A Preliminary Report 105
Cognitive remediation in schizophrenia: background, techniques, evidence of efficacy and perspectives 104
A reconsideration of the relationship between cerebral structural abnormalities and family history of schizophrenia. 103
A genome-wide search for schizophrenia susceptibility genes. 102
Lack of evidence for linkage to chromosomes 13 and 8 for schizophrenia and schizoaffective disorder 102
Evidence for linkage to psychosis and cerebral asymmetry (relative hand skill) on the X chromosome 101
Early life events and affective disorder revisited. 101
Patterns of Structural MRI Abnormalities in Deficit and Nondeficit Schizophrenia. 101
Persistence of effectiveness of cognitive remediation interventions in schizophrenia: A 1-year follow-up study. 101
Autistic symptoms predict social cognitive performance in patients with schizophrenia 101
Antipsychotic drugs v. barbiturates or benzodiazepines used as active placebos for schizophrenia: a systematic review and meta-analysis 101
Longitudinal studies of brain morphology and outcome of schizophrenic disorder 100
Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates 100
Il rimedio cognitivo nelle psicosi: principi e metodi. 99
The effects of antipsychotic treatment on cerebral structure and function in schizophrenia. 99
Historical, psychopathological, neurological, and neuropsychological aspects of deficit schizophrenia: a multicenter study. 98
Factors related to different reasons for antipsychotic drug discontinuation in the treatment of schizophrenia: A naturalistic 18-month follow-up study. 98
Cognitive Remediation Therapy (CRT): presupposti e descrizione. 98
Structural brain abnormalities in bipolar disorder: what meta-analyses tell us 97
Il training cognitivo della Terapia Psicologica Integrata (IPT): presupposti e descrizione. 97
Magnetic resonance imaging findings in schizophrenia: relationships with language and thought disorders, symptomatology and cognitive performance. 97
Gray matter, white matter, brain, and intracranial volumes in first-episode bipolar disorder: a meta-analysis of magnetic resonance imaging studies 97
Failure to find a chromosome 18 pericentric linkage in families with schizophrenia 96
Uso della PET e della SPECT in psichiatria 96
Neuromorphological correlates of mood disorders: focus on cerebral ventricular enlargement. 96
Language and thought disorder in schizophrenia: brain morphological correlates. 95
Hippocampal and amygdala volume reductions in first-episode schizophrenia. 95
Cortical atrophy in schizophrenia: prevalence and associated features 95
Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies. 95
Cognitive remediation in schizophrenia: a controlled study 94
Outcome of positive and negative symptoms during neuroleptic therapy in schizophrenia 94
Cerebral ventricular abnormalities in schizophrenia: evidence of their early origin and stability over time. 94
Male siblings with schizophrenia share alleles at the androgen receptor above chance expectation. 94
Personal resources and depression in schizophrenia: The role of self-esteem, resilience and internalized stigma 93
Non-selective impairment of Wisconsin Card Sorting Test performance in patients with schizophrenia. 92
Qualitative MRI findings in patients with schizophrenia: a controlled study. 92
CT scan abnormalities and outcome of chronic schizophrenia 92
Poor adherence to antipsychotic medication in people with schizophrenia: diffusion, consequences and contributing factors. 92
Cerebral ventricular enlargement as a generalized feature of schizophrenia: a distribution analysis on 502 subjects. 91
Psychosocial Rehabilitation in Italy Today 91
Neurobiological and clinical effect of metacognitive interpersonal therapy vs structured clinical model: study protocol for a randomized controlled trial 91
COMT Val(158)Met and BDNF C(270)T polymorphisms in schizophrenia: a case-control study. 90
No evidence for a parent-of-origin effect detected in the pattern of inheritance of schizophrenia. 90
CLINICAL ASSESSMENT OF COGNITIVE IMPAIRMENT IN SCHIZOPHRENIA THROUGH THE SCHIZOPHRENIA COGNITION RATING SCALE: A VALIDATION STUDY IN THE ITALIAN POPULATION 90
Clinical-biological patterns and prediction of response to haloperidol in schizophrenia 90
Real-world effectiveness of long acting aripiprazole: Treatment persistence and its correlates in the Italian clinical practice 90
Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. 89
La cognitività sociale nella schizofrenia: modelli interpretativi e strategie di intervento 88
Stability of cerebral ventricular size from the appearance of the first psychotic symptoms to the later diagnosis of schizophrenia. 88
Brain density patterns in schizophrenia 88
Totale 11.477
Categoria #
all - tutte 116.374
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 116.374


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.068 0 0 0 0 0 0 0 0 0 0 544 524
2019/20206.632 986 173 176 646 352 758 679 733 455 841 421 412
2020/20214.794 111 581 191 497 185 580 143 534 541 572 604 255
2021/20222.574 185 463 58 150 39 124 123 200 136 284 188 624
2022/20233.141 411 30 31 329 246 798 28 366 550 54 153 145
2023/20242.429 207 90 249 209 167 558 109 84 634 81 41 0
Totale 25.552